These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26277546)

  • 1. The locoregional recurrence post-mastectomy for ductal carcinoma in situ: Incidence and risk factors.
    Bannani S; Rouquette S; Bendavid-Athias C; Tas P; Levêque J
    Breast; 2015 Oct; 24(5):608-12. PubMed ID: 26277546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ.
    Childs SK; Chen YH; Duggan MM; Golshan M; Pochebit S; Punglia RS; Wong JS; Bellon JR
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):948-52. PubMed ID: 22975615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery.
    Guillot E; Vaysse C; Goetgeluck J; Falcou MC; Couturaud B; Fitoussi A; Fourchotte V; Laki F; Malhaire C; Sigal-Zafrani B; Sastre-Garau X; Bollet MA; Mosseri V; Reyal F
    Breast; 2014 Apr; 23(2):97-103. PubMed ID: 24388733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of patients with ductal carcinoma in situ and sentinel node biopsy.
    Meretoja TJ; Heikkilä PS; Salmenkivi K; Leidenius MH
    Ann Surg Oncol; 2012 Jul; 19(7):2345-51. PubMed ID: 22395995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyzing the risk of recurrence after mastectomy for DCIS: a new use for the USC/Van Nuys Prognostic Index.
    Kelley L; Silverstein M; Guerra L
    Ann Surg Oncol; 2011 Feb; 18(2):459-62. PubMed ID: 20859695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
    Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in patients treated with mastectomy for ductal carcinoma in situ.
    Owen D; Tyldesley S; Alexander C; Speers C; Truong P; Nichol A; Wai ES
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e129-34. PubMed ID: 23195778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Local Recurrence After Simple and Skin-Sparing Mastectomy Performed in Patients with Ductal Carcinoma In Situ.
    Timbrell S; Al-Himdani S; Shaw O; Tan K; Morris J; Bundred N
    Ann Surg Oncol; 2017 Apr; 24(4):1071-1076. PubMed ID: 27837296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic invasive breast cancer recurrence following curative-intent therapy for ductal carcinoma in situ.
    Al Mushawah F; Rastelli A; Pluard T; Margenthaler JA
    J Surg Res; 2012 Mar; 173(1):10-5. PubMed ID: 21696764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.
    Dieterich M; Hartwig F; Stubert J; Klöcking S; Kundt G; Stengel B; Reimer T; Gerber B
    Breast; 2014 Aug; 23(4):346-51. PubMed ID: 24559611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.
    Bijker N; Peterse JL; Duchateau L; Julien JP; Fentiman IS; Duval C; Di Palma S; Simony-Lafontaine J; de Mascarel I; van de Vijver MJ
    J Clin Oncol; 2001 Apr; 19(8):2263-71. PubMed ID: 11304780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer local recurrence after mastectomy and TRAM flap reconstruction: incidence and treatment options.
    Howard MA; Polo K; Pusic AL; Cordeiro PG; Hidalgo DA; Mehrara B; Disa JJ
    Plast Reconstr Surg; 2006 Apr; 117(5):1381-6. PubMed ID: 16641702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion.
    Mamtani A; Nakhlis F; Downs-Canner S; Zabor EC; Morrow M; King TA; Van Zee KJ
    Ann Surg Oncol; 2019 Dec; 26(13):4264-4271. PubMed ID: 31440931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast.
    Lee LA; Silverstein MJ; Chung CT; Macdonald H; Sanghavi P; Epstein M; Holmes DR; Silberman H; Ye W; Lagios MD
    Am J Surg; 2006 Oct; 192(4):416-9. PubMed ID: 16978940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chest wall relapse after mastectomy for ductal carcinoma in situ: a report of 10 cases with a review of the literature.
    Kim JH; Tavassoli F; Haffty BG
    Cancer J; 2006; 12(2):92-101. PubMed ID: 16630397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.
    Prescrire Int; 2013 Dec; 22(144):298-303. PubMed ID: 24600734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem?
    Sacchini V; Pinotti JA; Barros AC; Luini A; Pluchinotta A; Pinotti M; Boratto MG; Ricci MD; Ruiz CA; Nisida AC; Veronesi P; Petit J; Arnone P; Bassi F; Disa JJ; Garcia-Etienne CA; Borgen PI
    J Am Coll Surg; 2006 Nov; 203(5):704-14. PubMed ID: 17084333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.